Cargando…

Ocular cicatricial pemphigoid following Dipeptidyl Peptidase-4 inhibitor use: A case report

PURPOSE: To report a rare Ocular Cicatricial Pemphigoid (OCP) case in a patient taking a Dipeptidyl Peptidase-4 Inhibitor (DPP-4 inhibitor), a medication used for the management of type 2 diabetes, for at least six years. OBSERVATIONS: A 64-year-old male presented with refractory bilateral conjuncti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsumoto, Akifumi, Fukuoka, Hideki, Yoneda, Akiko, Yokoi, Norihiko, Sotozono, Chie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682828/ https://www.ncbi.nlm.nih.gov/pubmed/38035149 http://dx.doi.org/10.1016/j.ajoc.2023.101957

Ejemplares similares

Ocular cicatricial pemphigoid
por: Stan, Cristina, et al.
Publicado: (2020)

Ocular cicatricial pemphigoid (Review)
por: Branisteanu, Daniel Constantin, et al.
Publicado: (2020)

Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
por: Tasanen, Kaisa, et al.
Publicado: (2019)

Clinical Approach to Ocular Cicatricial Pemphigoid
por: Çiftçi, Mukaddes Damla, et al.
Publicado: (2023)

Bullous pemphigoid associated with use of dipeptidyl peptidase-4 inhibitor
por: Kano, Yasuhiro, et al.
Publicado: (2022)

T-helper 17 lymphocytes in ocular cicatricial pemphigoid
por: Lambiase, Alessandro, et al.
Publicado: (2009)

Bullous pemphigoid with dipeptidyl peptidase‐4 inhibitors: Clinical features and pathophysiology
por: Murakami, Takaaki, et al.
Publicado: (2019)

Co-medications and dipeptidyl peptidase-4 inhibitors associated bullous pemphigoid()()
por: Gravani, Agoritsa, et al.
Publicado: (2021)

Improvement in ocular cicatricial pemphigoid following treatment for porphyria cutanea tarda
por: Ford, R Marshall, et al.
Publicado: (2012)

Ocular cicatricial pemphigoid treated with intramuscular corticotropin injections
por: Chen, Edward, et al.
Publicado: (2020)

Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitor – A case report
por: Karthik, S, et al.
Publicado: (2019)

Pemphigoid Nodularis Induced by Long-Term Use of Dipeptidyl Peptidase-4 Inhibitors
por: Norikawa, Natsumi, et al.
Publicado: (2023)

Bullous pemphigoid associated with dipeptidyl peptidase‐4 inhibitors: A report of five cases
por: Yoshiji, Satoshi, et al.
Publicado: (2017)

Ocular cicatricial pemphigoid masquerading as chronic conjunctivitis: a case report
por: DaCosta, Joanna
Publicado: (2012)

Adrenocorticotropic hormone analogue as novel treatment regimen in ocular cicatricial pemphigoid
por: Sharon, Yael, et al.
Publicado: (2018)

Implantation of XEN gel stent in a patient with ocular cicatricial pemphigoid
por: Zhou, Yujia, et al.
Publicado: (2023)

Dipeptidyl Peptidase-4 Inhibitors Cause Bullous Pemphigoid in Diabetic Patients: Report of Two Cases
por: Pasmatzi, Efi, et al.
Publicado: (2011)

Clinical, Laboratory and Histological Features of Dipeptidyl Peptidase-4 Inhibitor Related Noninflammatory Bullous Pemphigoid
por: Kinyó, Ágnes, et al.
Publicado: (2021)

Corneal perforation in ocular cicatricial pemphigoid: A CARE-compliant case report
por: Hwang, Suan, et al.
Publicado: (2021)

Cicatricial pemphigoid presenting as desquamative gingivitis
por: Chou, Hou-Chiang, et al.
Publicado: (2020)

Bullous Pemphigoid Associated with the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin in a Patient with Liver Cirrhosis Complicated with Rapidly Progressive Hepatocellular Carcinoma
por: Harada, Masaru, et al.
Publicado: (2017)

Dipeptidyl peptidase‐4 inhibitors‐associated bullous pemphigoid: A retrospective study of 168 pemphigoid and 9,304 diabetes mellitus patients
por: Kawaguchi, Yohei, et al.
Publicado: (2018)

The association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors: a ten-year prospective observational study
por: Lambadiari, Vaia, et al.
Publicado: (2021)

Dipeptidyl Peptidase-4 Inhibitor-Related Bullous Pemphigoid: Clinical, Laboratory, and Histological Features, and Possible Pathogenesis
por: Hung, Chih-Tsung, et al.
Publicado: (2022)

Dipeptidyl-Peptidase 4 Inhibitor-Induced Variants of Bullous Pemphigoid: A Case Series of Four Patients
por: Balighi, Kamran, et al.
Publicado: (2022)

Lisinopril prevents bullous pemphigoid induced by dipeptidyl peptidase 4 inhibitors via the Mas receptor pathway
por: Nozawa, Keisuke, et al.
Publicado: (2023)

Ocular-muscle surgery for filamentary keratitis that developed in double elevator palsy
por: Hieda, Osamu, et al.
Publicado: (2017)

Bullous pemphigoid associated with dipeptidyl peptidase‐4 inhibitor showing unfavorable outcomes despite immediate discontinuation of medication
por: Shinohara, Yasutake, et al.
Publicado: (2020)

New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors
por: Cui, Chenkai, et al.
Publicado: (2022)

Efficacy and adverse reactions of methotrexate in the treatment of ocular cicatricial pemphigoid: A case series study
por: Shi, Yewen, et al.
Publicado: (2018)

Perioperative Management and Long-Term Outcomes in Ocular Cicatricial Pemphigoid Patients Undergoing Cataract Surgery
por: He, Yuan, et al.
Publicado: (2022)

Combination Therapy of Plasma Exchange and Rituximab to Treat Cicatricial Pemphigoid and Bullous Pemphigoid
por: Kunadia, Anuj, et al.
Publicado: (2021)

The association between clinical and laboratory findings of bullous pemphigoid and dipeptidyl peptidase-4 inhibitors in the elderly: a retrospective study
por: Bukvić Mokos, Zrinka, et al.
Publicado: (2020)

Bullous Pemphigoid Associated with Dipeptidyl Peptidase 4 Inhibitors for the Treatment of Type 2 Diabetes: A Multicenter Study in Istanbul
por: Ugurer, Ece, et al.
Publicado: (2022)

Serum and Adipose Dipeptidyl Peptidase 4 in Cardiovascular Surgery Patients: Influence of Dipeptidyl Peptidase 4 Inhibitors
por: Shibasaki, Ikuko, et al.
Publicado: (2022)

The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors
por: Kim, Na-Hyung, et al.
Publicado: (2014)

Retracted: Perioperative Management and Long-Term Outcomes in Ocular Cicatricial Pemphigoid Patients Undergoing Cataract Surgery
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023)

Case Report: Appearance of Various Disease-Specific Antibodies After the Onset of Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
por: Iwamoto, Yuichiro, et al.
Publicado: (2022)

Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180
por: Mai, Yosuke, et al.
Publicado: (2019)

Clinical Features and Outcomes of Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid (DPP4i-Associated BP) in Thai Patients
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l4vbtjqfu3q23i58a64h5tek8q